These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9804214)

  • 1. A comparative prospective study of a chronic low dose versus a conventional ovulation stimulation regimen using recombinant human follicle stimulating hormone in anovulatory infertile women.
    Hedon B; Hugues JN; Emperaire JC; Chabaud JJ; Barbereau D; Boujenah A; Howles CM; Truong F
    Hum Reprod; 1998 Oct; 13(1O):2688-92. PubMed ID: 9804214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial.
    Calaf Alsina J; Ruiz Balda JA; Romeu Sarrió A; Caballero Fernández V; Cano Trigo I; Gómez Parga JL; González Batres C; Rodríguez Escudero FJ
    BJOG; 2003 Dec; 110(12):1072-7. PubMed ID: 14664878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative prospective study of conventional regimen with chronic low-dose administration of follicle-stimulating hormone for anovulation associated with polycystic ovary syndrome.
    Homburg R; Levy T; Ben-Rafael Z
    Fertil Steril; 1995 Apr; 63(4):729-33. PubMed ID: 7890055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase IV, open-label, randomized study of low-dose recombinant human follicle-stimulating hormone protocols for ovulation induction.
    Serour GI; Aboulghar M; Al Bahar A; Hugues JN; Esmat K
    Reprod Biol Endocrinol; 2014 Jun; 12():52. PubMed ID: 24942155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chronic low dose follicle stimulating hormone step-up regimen in the treatment of polycystic ovary syndrome related anovulatory infertility with clomiphene resistance].
    Chen W; Zhang Y; Dai Q
    Zhonghua Fu Chan Ke Za Zhi; 2000 Oct; 35(10):588-90. PubMed ID: 11372406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effectiveness and safety of recombinant human LH to support follicular development induced by recombinant human FSH in WHO group I anovulation: evidence from a multicentre study in Spain.
    Burgués S;
    Hum Reprod; 2001 Dec; 16(12):2525-32. PubMed ID: 11726569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary follicle-stimulating hormone for normogonadotropic clomiphene-resistant anovulatory infertility: prospective, randomized comparison between low dose step-up and step-down dose regimens.
    van Santbrink EJ; Fauser BC
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3597-602. PubMed ID: 9360513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human luteinizing hormone to trigger ovulation: randomized, controlled, dose-finding pilot study in ovulation induction.
    Pierson RA; Olatunbosun OA; Chizen DR; Saunders H; Loumaye E; De Moustier B
    J Reprod Med; 2014; 59(7-8):355-66. PubMed ID: 25098025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A randomized, single-blind, parallel-controlled and multicentre study: compare the efficacy and safety of domestic and imported human recombinant FSH in WHO group Ⅱ anovulatory infertility].
    Zhou YZ; Shen H; Zuo WL; Xu YH; Deng XH; Chen YL; Gao Y; Wang XX; Xu W; Lai QH; Shi H; Liu W; He Q; He FF
    Zhonghua Fu Chan Ke Za Zhi; 2016 Apr; 51(4):258-63. PubMed ID: 27116983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of two dosages of recombinant human follicle-stimulating hormone in Chinese women undergoing controlled ovarian stimulation: prospective randomised double-blind study.
    Ng EY; Yeung WS; Ho PC
    Hong Kong Med J; 2000 Dec; 6(4):368-74. PubMed ID: 11177158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of recombinant follicle stimulating hormone (Puregon) in infertile women pituitary-suppressed with triptorelin undergoing in-vitro fertilization: a prospective, randomized, assessor-blind, multicentre trial.
    Hedon B; Out HJ; Hugues JN; Camier B; Cohen J; Lopes P; Zorn JR; van der Heijden B; Coelingh Bennink HJ
    Hum Reprod; 1995 Dec; 10(12):3102-6. PubMed ID: 8822422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of a decremental dose regimen in patients treated with a chronic low-dose step-up protocol for WHO Group II anovulation: a prospective randomized multicentre study.
    Hugues JN; Cédrin-Durnerin I; Howles CM; ; Amram M; Angelini A; Balen A; Barbereau D; Birkhauser M; Boujenah A; De Leo V; De Placido G; Dessole S; Favrin S; Ferrazi E; Gay C; Germond M; Hedon B; Hocke C; Jolly C; Lamarca-Roth E; Lanzone A; Marchand F; Marcolin G; Mascaretti G; Moreau L; Massobrio M; Nappi C; Pardi G; Pennehouat G; Porcu E; Seibert M; Selvaggi L; Thiers D; Venturini P
    Hum Reprod; 2006 Nov; 21(11):2817-22. PubMed ID: 16877376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary follicle-stimulating hormone (FSH) versus recombinant FSH in clomiphene citrate-resistant, normogonadotropic,chronic anovulation: a prospective randomized study.
    Yarali H; Bukulmez O; Gurgan T
    Fertil Steril; 1999 Aug; 72(2):276-81. PubMed ID: 10438995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant follicle-stimulating hormone (FSH; Puregon) is more efficient than urinary FSH (Metrodin) in women with clomiphene citrate-resistant, normogonadotropic, chronic anovulation: a prospective, multicenter, assessor-blind, randomized, clinical trial. European Puregon Collaborative Anovulation Study Group.
    Coelingh Bennink HJ; Fauser BC; Out HJ
    Fertil Steril; 1998 Jan; 69(1):19-25. PubMed ID: 9457926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative randomized multicentric study comparing the step-up versus step-down protocol in polycystic ovary syndrome.
    Christin-Maitre S; Hugues JN;
    Hum Reprod; 2003 Aug; 18(8):1626-31. PubMed ID: 12871872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovulation induction in clomiphene-resistant anovulatory women: differential follicular response to purified urinary follicle-stimulating hormone (FSH) versus purified urinary FSH and luteinizing hormone.
    Hoffman DI; Lobo RA; Campeau JD; Tsai HM; Holmberg EA; Ono T; Frederick JJ; Platt LD; diZerega GS
    J Clin Endocrinol Metab; 1985 May; 60(5):922-7. PubMed ID: 3920235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gonadotrophin induction of ovulation using a step-down dose regimen: single-centre clinical experience in 82 patients.
    van Santbrink EJ; Donderwinkel PF; van Dessel TJ; Fauser BC
    Hum Reprod; 1995 May; 10(5):1048-53. PubMed ID: 7657739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of Ovaleap® (recombinant human follicle-stimulating hormone) for up to 3 cycles in infertile women using assisted reproductive technology: a phase 3 open-label follow-up to Main Study.
    Strowitzki T; Kuczynski W; Mueller A; Bias P
    Reprod Biol Endocrinol; 2016 Jun; 14(1):31. PubMed ID: 27287439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential low-dose step-up and step-down protocols with recombinant follicle-stimulating hormone in polycystic ovary syndrome: prospective comparison with step-down protocol.
    Casadei L; Puca F; Emidi E; Manicuti C; Madrigale A; Piccione E
    Arch Gynecol Obstet; 2012 Nov; 286(5):1291-7. PubMed ID: 22729136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian stimulation in women undergoing in-vitro fertilization and embryo transfer using recombinant human follicle stimulating hormone (Gonal-F) in non-down-regulated cycles.
    Strowitzki T; Kentenich H; Kiesel L; Neulen J; Bilger W
    Hum Reprod; 1995 Dec; 10(12):3097-101. PubMed ID: 8822421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.